A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody ; volume:8 ; number:1 ; day:12 ; month:3 ; year:2018 ; pages:1-15 ; date:12.2018
Scientific reports ; 8, Heft 1 (12.3.2018), 1-15, 12.2018
- Urheber
-
Nogales, Aitor
- Beteiligte Personen und Organisationen
-
Piepenbrink, Michael S.
Wang, Jiong
Ortega, Sandra
Basu, Madhubanti
Fucile, Christopher F.
Treanor, John J.
Rosenberg, Alexander F.
Zand, Martin S.
Keefer, Michael C.
Martinez-Sobrido, Luis
Kobie, James J.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-22307-8
- URN
-
urn:nbn:de:1111-201805125490
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nogales, Aitor
- Piepenbrink, Michael S.
- Wang, Jiong
- Ortega, Sandra
- Basu, Madhubanti
- Fucile, Christopher F.
- Treanor, John J.
- Rosenberg, Alexander F.
- Zand, Martin S.
- Keefer, Michael C.
- Martinez-Sobrido, Luis
- Kobie, James J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
Broadly Neutralizing Antibodies for HIV Eradication
Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
Broadly Neutralizing Antibodies for HIV Eradication
Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
A broadly neutralizing monoclonal antibody induces broad protection against heterogeneous PRRSV strains in piglets
Broadly Neutralizing Antibodies for HIV Eradication
Novel computational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates
The expanding array of HIV broadly neutralizing antibodies